Publication | Open Access
Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
82
Citations
29
References
2016
Year
In addition to the pathologic parameters and biomarkers already routinely assessed, evaluation of TLI and SLI may help to better select patients with HER2+ and TNBC for neoadjuvant chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1